13 October
J. Craig Venter has won this year's Economist Innovation Award for Bioscience. Dr Venter, president of the J. Craig Venter Institute (JCVI)(www.jcvi.org), Is to be honoured for his genomic research and its potential "to revolutionise personal medicine, pharmaceuticals and biofuels." At the forefront of genomic research for almost two decades, Dr Venter's discoveries have been said to open up the scientific research of the microbial world and how it affects humans.
Commenting on his award, Dr Venter said: "We are now in a world 100% dependent on scientific innovation. Innovation is the key driver for success, especially in challenging economic times."
The award will be presented at a ceremony at London's Science museum on October 29th. The Economist's Innovation Summit, focusing on the interface between innovation and business, will take place the following day.
For more information on the winner and the award, click here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.